William Blair Brokers Lower Earnings Estimates for SPRY
ARS Pharmaceuticals, Inc. (NASDAQ:SPRY – Free Report) – Equities researchers at William Blair dropped their Q2 2025 earnings per share (EPS) estimates for ARS Pharmaceuticals in a research report issued to clients and investors on Wednesday, May 14th. William Blair analyst L. Hanbury-Brown now forecasts that the company will post earnings per share of ($0.44) […]
ARS Pharmaceuticals, Inc. (NASDAQ:SPRY – Free Report) – Equities researchers at William Blair dropped their Q2 2025 earnings per share (EPS) estimates for ARS Pharmaceuticals in a research report issued to clients and investors on Wednesday, May 14th. William Blair analyst L. Hanbury-Brown now forecasts that the company will post earnings per share of ($0.44) […]
